The Chemours Company
CC · NYSE
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 5, 2026 | — | 1.65B | — | 0.43 | — |
| 2026 Q1 | May 6, 2026 | 1.38B | 1.40B | -0.19 | -0.05 | -15.28% |
| 2025 Q4 | February 20, 2026 | 1.33B | 1.33B | -0.31 | 0.09 | -16.51% |
| 2025 Q3 | November 7, 2025 | 1.50B | 1.33B | 0.20 | 0.24 | +6.56% |
| 2025 Q2 | August 6, 2025 | 1.62B | 1.54B | 0.58 | 0.46 | -4.99% |
| 2025 Q1 | May 7, 2025 | 1.37B | 1.35B | 0.13 | 0.19 | -9.92% |
| 2024 Q4 | February 18, 2025 | 1.39B | 1.38B | 0.11 | 0.10 | +3.86% |
| 2024 Q3 | November 4, 2024 | 1.50B | 1.35B | 0.40 | 0.32 | +15.49% |
| 2024 Q2 | August 2, 2024 | 1.54B | 1.53B | 0.38 | 0.66 | -11.88% |
| 2024 Q1 | May 1, 2024 | 1.35B | 1.35B | 0.32 | 0.25 | -2.80% |
| 2023 Q4 | March 28, 2024 | 1.36B | 1.32B | 0.31 | 0.29 | — |
| 2023 Q3 | October 27, 2023 | 1.49B | 1.53B | 0.64 | 0.77 | -2.72% |
| 2023 Q2 | July 28, 2023 | 1.64B | 1.69B | 1.10 | 1.09 | -3.64% |
| 2023 Q1 | April 28, 2023 | 1.54B | 1.72B | 0.98 | 0.62 | +4.01% |
| 2022 Q4 | February 10, 2023 | 1.34B | 1.27B | -0.65 | 0.15 | +2.54% |
| 2022 Q3 | October 26, 2022 | 1.78B | 1.67B | 1.24 | 1.16 | +0.59% |